Ultralife Corporation
ULBI
$6.85
-$0.10-1.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -4.31% | 15.72% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -4.31% | 15.72% | |||
| Cost of Revenue | -2.64% | 14.10% | |||
| Gross Profit | -9.25% | 20.81% | |||
| SG&A Expenses | 1.07% | -2.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.15% | 10.64% | |||
| Operating Income | -32.67% | 192.81% | |||
| Income Before Tax | -54.50% | 394.14% | |||
| Income Tax Expenses | -57.14% | 116.41% | |||
| Earnings from Continuing Operations | -53.70% | 706.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 164.29% | 64.10% | |||
| Net Income | -52.87% | 861.34% | |||
| EBIT | -32.67% | 192.81% | |||
| EBITDA | -22.43% | 105.53% | |||
| EPS Basic | -52.90% | 858.12% | |||
| Normalized Basic EPS | -50.71% | 1,320.29% | |||
| EPS Diluted | -54.55% | 937.74% | |||
| Normalized Diluted EPS | -50.67% | 1,336.76% | |||
| Average Basic Shares Outstanding | 0.01% | 0.02% | |||
| Average Diluted Shares Outstanding | -0.14% | -0.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||